Novel variants of the Smqnr family of quinolone resistance genes in clinical isolates of Stenotrophomonas maltophilia

Journal of Antimicrobial Chemotherapy

Volumn 65, Issue 3, 2010, Pages 483-489

  Gordon, N C ^a   Wareham, D W ^a,b,c  

^a BARTS HEALTH NHS TRUST   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Enterobacteriaceae; Pentapeptide repeat proteins; Plasmids

Indexed keywords

BACTERIAL PROTEIN; PROTEIN SMQNR; QUINOLONE; UNCLASSIFIED DRUG;

ALLELE; AMINO ACID SEQUENCE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; DNA SEQUENCE; ESCHERICHIA COLI; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC VARIABILITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; SEQUENCE ANALYSIS; STENOTROPHOMONAS MALTOPHILIA;

AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; CLONING, MOLECULAR; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; GENES, BACTERIAL; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; QUINOLONES; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, DNA; STENOTROPHOMONAS MALTOPHILIA; TRANSFORMATION, BACTERIAL;

EID: 77950325646     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkp476     Document Type: Article

References (26)

1. Denton M, Kerr KG. Microbiological and clinical aspects of infection with Stenotrophomonas maltophilia. Clin Microbiol Rev 1998; 11: 57-80.
2. Ferrara AM. Potentially multidrug-resistant non-fermentative Gram-negative pathogens causing nosocomial pneumonia. Int J Antimicrob Agents 2006; 27: 183-95.
3. Nicodemo AC, Araujo MR, Ruiz AS et al. In vitro susceptibility of Stenotrophomonas maltophilia isolates: comparison of disc diffusion, Etest and agar dilution methods. J Antimicrob Chemother 2004; 53: 604-8.
4. Nicodemo AC, Paez JI. Antimicrobial therapy for Stenotrophomonas maltophilia infection. Eur J Clin Microbiol Infect Dis 2007; 26: 227-37.
5. Avison MB, Higgins CS, von Heldreich CJ et al. Plasmid location and molecular heterogeneity of the L1 and L2 β-lactamase genes of Stenotrophomonas maltophilia. Antimicrob Agents Chemother 2001; 45: 413-9.
6. Poole K. Efflux-mediated resistance in Gram-negative bacteria. Clin Microbiol Infect 2004; 10: 12-26.
7. Crossman LC, Gould VC, Dow JM et al. The complete genome, comparative and functional analysis of Stenotrophomonas maltophilia reveals an organism heavily shielded by drug resistance determinants. Genome Biol 2008; 9: R74.
8. Shimizu K, Kikuchi K, Sasaki T et al. Smqnr, a new chromosome-carried quinolone resistance gene in Stenotrophomonas maltophilia. Antimicrob Agents Chemother 2008; 52: 3823-5.
9. Poirel L, Villa L, Bertini A et al. Extended-spectrum b-lactamase and plasmid-mediated quinolone resistance. Emerg Infect Dis 2007; 13: 803-5.
10. Poirel L, Cattoir V, Nordmann P. Is plasmid-mediated quinolone resistance a clinically significant problem? Clin Microbiol Infect 2008; 14: 295-7.
11. Valdezate S, Vindel A, Echeita A et al. Topoisomerase II and IV quinolone resistance-determining regions in Stenotrophomonas maltophilia clinical isolates with different levels of quinolone susceptibility. Antimicrob Agents Chemother 2002; 46: 665-71.
12. Ribera A, Doménech-Sanchez A, Ruiz J et al. Mutations in gyrA and parC QRDRs are not relevant for quinolone resistance in epidemiological unrelated Stenotrophomonas maltophilia clinical isolates. Microb Drug Resist 2002; 8: 245-51.
13. Valdezate S, Vindel A, Baquero F et al. Comparative in-vitro activity of quinolones against Stenotrophomonas maltophilia. Eur J Clin Microbiol Infect Dis 1999; 18: 908-11.
14. Murray A, Mather H, Coia JE et al. Plasmid-mediated quinolone resistance in nalidixic-acid-susceptible strains of Salmonella enterica isolated in Scotland. J Antimicrob Chemother 2008; 62: 1153-5.
15. Andrews JM. BSAC standardized disc susceptibility testing method (version 7). J Antimicrob Chemother 2008; 62: 256-78.
16. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Seventeenth Informational Supplement M100-S17. CLSI, Wayne, PA, USA, 2007.
17. Jacoby G, Cattoir V, Hooper D. qnr gene nomenclature. Antimicrob Agents Chemother 2008; 52: 2297-9.
18. Thompson J, Higgins DDG, Gibson TJ. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994; 22: 4673-80.
19. Rosco Diagnostica. Neo-Sensitabs Susceptibility Testing User's Guide. 19th edn. Tastrup, Denmark: Rosco Diagnostica, 2007.
20. Cavaco LM, Hasman H, Xia S et al. qnrD, a novel gene conferring transferable quinolone resistance in Salmonella enterica serovar Kentucky and Bovismorbificans strains of human origin. Antimicrob Agents Chemother 2009; 53: 603-8.
21. Jacoby GA, Gacharna N, Black TA et al. Temporal appearance of plasmid-mediated quinolone resistance genes. Antimicrob Agents Chemother 2009; 53: 1665-6.
22. Arsene S, Leclercq R. Role of a qnr-like gene in the intrinsic resistance of Enterococcus faecalis to fluoroquinolones. Antimicrob Agents Chemother 2007; 51: 3254-8.
23. Cattoir V, Poirel L, Mazel D et al. Vibrio splendidus as the source of plasmid-mediated QnrS-like quinolone resistance determinants. Antimicrob Agents Chemother 2007; 51: 2650-1.
24. Fonseca EL, Dos Santos FF, Vieira VV et al. Newqnr gene cassettes associated with superintegron repeats in Vibrio cholerae O1. Emerg Infect Dis 2008; 14: 1129-31.
25. Saga T, Kaku M, Onodera Y et al. Vibrio parahaemolyticus chromosomal qnr homologue VPA0095: demonstration by transformation with a mutated gene of its potential to reduce quinolone susceptibility in Escherichia coli. Antimicrob Agents Chemother 2005; 49: 2144-5.
26. Sanchez M, Hernandez A, Rodriguez-Martinez J et al. Predictive analysis of transmissible quinolone resistance indicates Stenotrophomonas maltophilia as a potential source of a novel family of Qnr determinants. BMC Microbiol 2008; 8: 148.